Cor Vasa 2016, 58(2):e279-e286 | DOI: 10.1016/j.crvasa.2015.11.005
The role of arterial hypertension in the primary prevention of stroke
- Klinika kardiologie, Institut klinické a experimentální medicíny, Praha, Česká republika
Hypertension belongs to the most important modifiable risk factors of cerebrovascular diseases and stroke. Home or 24-hour ambulatory blood pressure measurement (ABPM) are preferable measurements of blood pressure. Nonpharmacologic treatment should include smoking abstinence, overweight reduction, restriction of alcohol intake and moderate consumption of salt.
Evidence based clinical studies have convincingly proved that drug therapy decreases the incidence of cerebrovascular diseases and stroke by 40-60%. Systolic blood pressure is more important than diastolic blood pressure in the elderly patients, in whom the majority of cerebrovascular diseases and strokes occurs.
A great discussion concentrates on the issue of goal values of blood pressure in the prevention of cerebrovascular diseases and stroke. Unfortunately all evidence based studies were performed only in patients with initial systolic blood pressure of 160 mm Hg and more.
Only 2 studies focused on the target systolic blood pressure in the stroke prevention. The ACCORD study compared target values of 120 and 140 mmHg. Target systolic pressure 120 mmHg was superior (over 140 mmHg) in stroke prevention, but not in prevention of other cardiovascular events (myocardial infarction or heart failure).
The recent SPRINT study found a decrease of total mortality in patients with target systolic blood pressure of 120 mmHg over those with 140 mmHg target. From the above mentioned studies seems the lower systolic blood pressure preferable.
Keywords: Arterial hypertension; Primary prevention
Received: November 9, 2015; Accepted: November 14, 2015; Published: April 1, 2016 Show citation
References
- V.L. Burt, P. Whelton, E.J. Roccella, et al., Prevalence of hypertension in the US adult population: results from the third National Health and Nutrition Examination Survey, 1988-1991, Hypertension 25 (1995) 305-313.
Go to original source...
Go to PubMed...
- B.M. Psaty, C.D. Furberg, L.H. Kuller, et al., Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality, Archives of Internal Medicine 161 (2001) 1183-1192.
Go to original source...
Go to PubMed...
- B. Williams, L. Lindholm, P. Sever, Systolic pressure is all that matters, Lancet 379 (2008) 2219-2221.
Go to original source...
Go to PubMed...
- A. Benetos, F. Thomas, K. Bean, et al., Prognostic value of systolic and diastolic blood pressure in treated hypertensive patients, Archives of Internal Medicine 162 (2002) 577-581.
Go to original source...
Go to PubMed...
- G. Mancia, R. Fagard, K. Narkiewicz, et al., 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), European Heart Journal 34 (2013) 2159-2219.
Go to original source...
- Prospective Studies Collaborators, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet 360 (2002) 1903-1913
Go to original source...
- H. Arima, J. Chalmers, M. Woodward, et al., Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial, Journal of Hypertension 24 (2006) 1201-1208.
Go to original source...
Go to PubMed...
- The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators, Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease; randomised, double-blind, placebo-controlled, multicenter trial (the EUROPA study), Lancet 362 (2003) 782-788.
- S. Yusuf, P. Sleight, J. Pogue, et al. Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients, The Heart Outcomes Prevention Evaluation (HOPE) Investigation, New England Journal of Medicine 342 (2000) 145-153.
Go to original source...
Go to PubMed...
- The ACCORD Study Group, Effects of intensive blood-pressure control in type 2 diabetes mellitus, New England Journal of Medicine 362 (2010) 1575-1585.
Go to original source...
Go to PubMed...
- W.L. Ooi, S. Barrett, M. Hosain, et al., Patterns of orthostatic blood pressure change and their clinical correlates in a frail, elderly population, Journal of the American Medical Association 277 (1997) 1299-1304.
Go to original source...
Go to PubMed...
- B. Dahlöf, L.H. Lindholm, L. Hansson, et al., Morbidity and mortality in the Swedish trial in Old Patients with Hypertension (STOP-Hypertension), Lancet 338 (1991) 1281-1285.
Go to original source...
Go to PubMed...
- Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party, British Medical Journal 304 (1992) 405-412.
- SHEP Cooperative Research Group, Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP), Journal of the American Medical Association 265 (1991) 3255-3264.
Go to original source...
- J.A. Staessen, R. Fagard, L. Thijs, et al., Morbidity and mortality in the placebo-controlled European Trial on Isolated Systolic Hypertension in the Elderly, Lancet 360 (1997) 757-764.
Go to original source...
Go to PubMed...
- L. Liu, J.G. Wang, I. Gong, et al., Comparison of active treatment and placebo in older patients with isolated systolic hypertension, Journal of Hypertension 16 (1998) 1823-1829.
Go to original source...
Go to PubMed...
- L. Hansson, T. Hedner, P. Lund-Johansen, et al., Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study, Lancet 356 (2000) 359-365.
Go to original source...
Go to PubMed...
- M.J. Brown, C.R. Palmer, A. Castaigne, et al., Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT), Lancet 256 (2000) 366-372.
Go to original source...
Go to PubMed...
- L. Hansson, L.H. Lindholm, T. Ekbom, et al., Randomised trial of old and new antihypertensives drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study, Lancet 354 (1999) 1751-1756.
Go to original source...
Go to PubMed...
- A. Zanchetti, Blood pressure targets of antihypertensive treatment up and down the J-shaped curve, European Heart Journal 31 (2010) 2837-2840.
Go to original source...
Go to PubMed...
- J.A. Staessen, J. Gasowski, J.G. Wang, et al., Risks of untreated and treated isolated hypertension in the elderly: meta-analysis of outcome trials, Lancet 357 (2001) 865-872. (Erratum, Lancet 357 (2001) 724).
Go to original source...
- Blood Pressure Lowering Treatment Trialists Collaboration, Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials, British Medical Journal 336 (2008) 1121-1123.
Go to original source...
Go to PubMed...
- The SPRINT Research Group, A randomized trial of intensive versus standard blood-pressure control, New England Journal of Medicine 373 (2015) 2103-2116.
Go to original source...
Go to PubMed...
- C.D. Furberg, B.M. Psaty, J.V. Meyer, Nifedipine: dose related increase in mortality in patients with coronary artery disease, Circulation 2 (1995) 1326-1331.
Go to original source...
Go to PubMed...
- B.N. Mukete, M. Cassidy, K.C. Ferdinand, T.H. Le Jemtel, Long-term anti-hypertensive therapy and stroke prevention. A meta-analysis, American Journal of Cardiovascular Drugs 15 (2015) 243-257.
Go to original source...
Go to PubMed...
- K. Kario, Th.G. Pickering, Y. Umeda, et al., Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives. A prospective study, Circulation 107 (2003) 1401-1406.
Go to original source...
Go to PubMed...
- K. Jamerson, G. Bakris, B. Dahlöf, et al., Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients, New England Journal of Medicine 359 (2008) 2417-2428.
Go to original source...
Go to PubMed...
- N.S. Beckett, R. Peters, A.E. Fletcher, et al., Treatment of hypertension in patients 80 years of age or older, New England Journal of Medicine 358 (2008) 1887-1898.
Go to original source...
Go to PubMed...